Physician profile
Jeffrey E Sell
NPI 1194719856
$6,925.34
in general payments reported to CMS, 2019-2025
22 companies · $1,737 in 2025
The $1,737 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,367 · 2020: $305 · 2021: $742 · 2022: $674 · 2023: $1,557 · 2024: $544 · 2025: $1,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,399 · Travel and Lodging: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,398.81 |
| Travel and Lodging | $438.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,477.41 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $688.33 | 2019-2025 | Synergy Ablation System |
| Coastal Medical Technologies LLC | $671.85 | 2025 | |
| Baxter Healthcare | $547.06 | 2021-2025 | Floseal, Tisseel |
| Arthrex, INC. | $482.45 | 2025 | |
| Biom'Up Sa | $354.63 | 2019 | |
| Abiomed | $347.44 | 2021-2025 | Impella |
| Medtronic Vascular, INC. | $214.69 | 2019 | |
| Abbott Laboratories | $187.98 | 2019 | |
| Getinge USA Sales, LLC | $169.91 | 2020-2023 | Cardioroot |
| Covidien Lp | $151.90 | 2019 | |
| Boston Scientific Corporation | $122.91 | 2020 | |
| Haemonetics Corporation | $102.27 | 2024 | Teg6s Hemostasis System |
| Davol INC. | $102.22 | 2020 | |
| Medtronic, INC. | $90.67 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.70 | 2021-2022 | |
| Lsi Solutions INC | $37.25 | 2019-2023 | Cor Knot |
| Artivion, INC. | $36.89 | 2019 | |
| Akcea Therapeutics, INC. | $36.04 | 2020 | |
| Biom'Up France Sas | $33.17 | 2020 | |
| Cvrx, INC. | $15.22 | 2025 | Barostim Neo System |
| Nuwellis, INC. | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Sell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.